David Patience - Feb 26, 2024 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)

Role
Chief Financial Officer
Signature
/s/ David Patience
Stock symbol
AXDX
Transactions as of
Feb 26, 2024
Transactions value $
-$336
Form type
4
Date filed
2/27/2024, 06:59 PM
Previous filing
Jan 25, 2024
Next filing
Mar 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXDX Common Stock Options Exercise $0 +1K +3.91% $0.00 26.6K Feb 26, 2024 Direct F1
transaction AXDX Common Stock Sale -$336 -350 -1.32% $0.96 26.2K Feb 26, 2024 Direct F2
holding AXDX Common Stock 760 Feb 26, 2024 By Spouse IRA

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXDX Employee Restricted Stock Units Options Exercise $0 -1K -40% $0.00 1.5K Feb 26, 2024 Common Stock 1K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 26, 2022, the reporting person was granted a total of 2,500 restricted stock units ("RSUs"), of which 40% vest on February 26, 2024 and the remaining 60% vest on February 26, 2025. Each RSU represents a contingent right to receive one share of the issuer's common stock for each RSU upon vesting.
F2 The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.